BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$344M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$266M |
| 3 |
Motorola Solutions
MSI
|
+$224M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$222M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$235M |
| 2 |
Alibaba
BABA
|
+$199M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$195M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$132M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.31% |
| 2 | Financials | 6.96% |
| 3 | Consumer Discretionary | 5.46% |
| 4 | Healthcare | 4.97% |
| 5 | Industrials | 4.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INST
2626
DELISTED
Instructure, Inc.
INST
| $200K | ﹤0.01% |
5,150
+1,415
| +38% | +$57.7K |
|
2627
Orthofix Medical
OFIX
$415M
| $199K | ﹤0.01% |
3,754
+171
| +5% | +$8.82K |
|
2628
Scotiabank
BNS
$110B
| $199K | ﹤0.01% |
3,500
| – | – |
|
2629
Hilton Grand Vacations
HGV
$3.49B
| $199K | ﹤0.01% |
6,215
+906
| +17% | +$28.5K |
|
2630
Schwab US Large- Cap ETF
SCHX
$75B
| $199K | ﹤0.01% |
16,812
+6,588
| +64% | +$77.6K |
|
2631
Matthews International
MATW
$725M
| $198K | ﹤0.01% |
5,608
-602
| -10% | -$19.8K |
|
2632
iShares Core S&P Total US Stock Market ETF
ITOT
$98.5B
| $198K | ﹤0.01% |
2,958
+1,167
| +65% | +$78.2K |
|
|
PRFT
2633
DELISTED
Perficient Inc
PRFT
| $198K | ﹤0.01% |
5,137
+735
| +17% | +$26.6K |
|
|
CHS
2634
DELISTED
Chicos FAS, Inc.
CHS
| $198K | ﹤0.01% |
49,159
+5,496
| +13% | +$18.6K |
|
|
VBTX
2635
DELISTED
Veritex Holdings
VBTX
| $198K | ﹤0.01% |
8,162
+3,256
| +66% | +$80.2K |
|
2636
Varex Imaging
VREX
$778M
| $198K | ﹤0.01% |
6,928
-289
| -4% | -$8.36K |
|
|
ACB
2637
Aurora Cannabis
ACB
$235M
| $197K | ﹤0.01% |
373
+108
| +41% | +$80K |
|
2638
Carlyle Group
CG
$17.2B
| $195K | ﹤0.01% |
7,624
-12,621
| -62% | -$302K |
|
|
TYPE
2639
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $195K | ﹤0.01% |
9,833
+2,824
| +40% | +$53.7K |
|
2640
Coherus Oncology
CHRS
$181M
| $195K | ﹤0.01% |
9,604
+3,810
| +66% | +$76.1K |
|
2641
Editas Medicine
EDIT
$432M
| $194K | ﹤0.01% |
8,538
+2,346
| +38% | +$58.1K |
|
|
JKS
2642
JinkoSolar
JKS
$860M
| $194K | ﹤0.01% |
12,161
+1,935
| +19% | +$38.9K |
|
2643
TFS Financial
TFSL
$4.89B
| $194K | ﹤0.01% |
10,739
+3,930
| +58% | +$70.4K |
|
2644
iShares MSCI Thailand ETF
THD
$354M
| $193K | ﹤0.01% |
2,180
-1,515
| -41% | -$138K |
|
|
RPT
2645
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $193K | ﹤0.01% |
14,219
-1,761
| -11% | -$21.7K |
|
|
CPE
2646
DELISTED
Callon Petroleum Company
CPE
| $193K | ﹤0.01% |
4,438
+2,040
| +85% | +$99.5K |
|
2647
CBIZ
CBZ
$2.96B
| $192K | ﹤0.01% |
8,188
-1,048
| -11% | -$23.6K |
|
2648
CALL
Energous
WATT
$93.4M
| $192K | ﹤0.01% |
1
| – | – |
|
2649
Perdoceo Education
PRDO
$1.96B
| $192K | ﹤0.01% |
12,077
-53,009
| -81% | -$1.04M |
|
2650
Genesco
GCO
$391M
| $192K | ﹤0.01% |
4,794
-605
| -11% | -$23.3K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2019 Portfolio in Review
As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 8.5% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $235M trimmed.
- BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
- BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
- BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
- BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
- BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
- BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
- BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.